Jane Alison Burch

Search results

• 2013

  Crizotinib for the treatment of previously treated non-small-cell lung cancer associated with an anaplastic lymphoma kinase (ALK) fusion gene: A Single Technology Appraisal.

  Duarte, A. I., Burch, J. A., Smith, A., Walker, S. M., Fox, D., Rodriguez-Lopez, R., Palmer, S. J. & Eastwood, A. J., 2013, NICE.

  Research output: Book/Report › Commissioned report

• 2011

  Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: a systematic review and economic evaluation: Evidence Review Group Report for the National Institute for Health and Care Excellence

  Spackman, E., Burch, J. A., Faria, R., Corbacho Martín, B., Fox, D. & Woolacott, N. F., 2011, National Institute for Health and Care Excellence. 132 p.

  Research output: Book/Report › Commissioned report
• 2007

  Diagnostic accuracy and cost-effectiveness of faecal occult blood tests (FOBT) used in screening for colorectal cancer: a systematic review

  Soares-Weiser, K., Burch, J., Duffy, S., St John, J., Smith, S., Westwood, M. & Kleijnen, J., Feb 2007, York: University of York. 237 p.

  Research output: Book/Report › Commissioned report